KAINOS Laboratories: Change report.
KAINOS Laboratories: March 2025 First Quarter Fiscal Results Announcement [Japanese Standards] (Non-consolidated)
KAINOS Laboratories: Report on Corporate Governance - July 25th, 2024.
KAINOS Laboratories: Regarding matters related to dominant shareholders.
KAINOS Laboratories: Report on Corporate Governance, June 21, 2024.
KAINOS Laboratories: Interim report
KAINOS Laboratories: Internal Control Report - 49th Term (2023/04/01 - 2024/03/31)
KAINOS Laboratories: Confirmation letter
KAINOS Laboratories: Securities report - 49th period (April 1, 2023 - March 31, 2024)
KAINOS Laboratories: Change report.
KAINOS LABORATORIES: 2024 Annual General Meeting of Shareholders Convocation Notice and Shareholders' Meeting Materials
KAINOS LABORATORIES: Notice regarding changes in officers
KAINOS LABORATORIES: Summary of financial results for the fiscal year ending March 31, 2024 [Japanese GAAP] (unconsolidated)
KAINOS LABORATORIES: Change Report
Kainos: Notice of commencement of manufacture and sale of 6 immunoassay reagents for gynecological/gonadal hormones
Kainos: Announcement of personnel changes
Kainos: Notice Concerning Revision of Dividend Forecast for the Fiscal Year Ending March 2024 (49th Term)
KAINOS Laboratories: Confirmation letter
KAINOS Laboratories: Quarterly Report - 49th Quarter 3rd Quarter (2023/10/01 - 2023/12/31)
KAINOS Laboratories: Corporate Governance Report 2024/01/25
No Data